Press Releases

Orgenesis Inc. , a provider of point-of-care cell and gene therapy development, processing and treatment solutions (“POCare”), announces the completion of the sale of its Masthercell Global, Inc. subsidiary, a contract development manufacturing organization (CDMO), to Catalent Pharma Solutions....

ACG Inspection–one of the four businesses of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry –has introduced an advanced blockchain-based solution that meets and exceeds traceability and anti-counterfeiting requirements in the...

BioXcel Therapeutics, Inc , a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to identify and advance the next wave of medicines in neuroscience and immuno-oncology, announced that its Investigational New Drug application for BXCL501, the Company’s proprietary sublingual thin-film...

Thermo Fisher Scientific introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze a broad range of key genetic markers with an end-to-end workflow. The Ion Torrent CarrierSeq ECS Kit for the Ion...

Vetter has brought together its development laboratories in one Ravensburg site end of last year. Designed to improve workflow and enhance customer benefits within the daily support in complex development projects, the services at the 1,800 sqm building include...

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that Nestlé Health Science will make an additional equity investment in Aimmune of $200 million, bringing Nestlé’s total investment in...

Assertio Therapeutics, Inc. announced it has entered into a definitive agreement with Collegium Pharmaceutical, Inc. pursuant to which Collegium will acquire the NUCYNTA franchise of products from the Company. The closing of the agreement is expected by February 14,...